JP2022505615A5 - - Google Patents

Info

Publication number
JP2022505615A5
JP2022505615A5 JP2021522019A JP2021522019A JP2022505615A5 JP 2022505615 A5 JP2022505615 A5 JP 2022505615A5 JP 2021522019 A JP2021522019 A JP 2021522019A JP 2021522019 A JP2021522019 A JP 2021522019A JP 2022505615 A5 JP2022505615 A5 JP 2022505615A5
Authority
JP
Japan
Application number
JP2021522019A
Other languages
Japanese (ja)
Other versions
JPWO2020092694A5 (https=
JP2022505615A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/059039 external-priority patent/WO2020092694A2/en
Publication of JP2022505615A publication Critical patent/JP2022505615A/ja
Publication of JPWO2020092694A5 publication Critical patent/JPWO2020092694A5/ja
Publication of JP2022505615A5 publication Critical patent/JP2022505615A5/ja
Pending legal-status Critical Current

Links

JP2021522019A 2018-10-31 2019-10-31 造血幹・前駆細胞移植療法の方法 Pending JP2022505615A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862753865P 2018-10-31 2018-10-31
US62/753,865 2018-10-31
US201962860866P 2019-06-13 2019-06-13
US62/860,866 2019-06-13
PCT/US2019/059039 WO2020092694A2 (en) 2018-10-31 2019-10-31 Methods for hematopoietic stem and progenitor cell transplant therapy

Publications (3)

Publication Number Publication Date
JP2022505615A JP2022505615A (ja) 2022-01-14
JPWO2020092694A5 JPWO2020092694A5 (https=) 2022-11-09
JP2022505615A5 true JP2022505615A5 (https=) 2022-11-09

Family

ID=70464231

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021522019A Pending JP2022505615A (ja) 2018-10-31 2019-10-31 造血幹・前駆細胞移植療法の方法

Country Status (7)

Country Link
US (1) US20210379113A1 (https=)
EP (1) EP3874027A4 (https=)
JP (1) JP2022505615A (https=)
CN (1) CN113302287A (https=)
AU (1) AU2019374064A1 (https=)
CA (1) CA3117685A1 (https=)
WO (1) WO2020092694A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230165958A1 (en) * 2020-04-27 2023-06-01 Children's Hospital Medical Center Precision Dosing Regimen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1011694A4 (en) * 1996-11-15 2000-11-15 Baxter Int TREATMENT FOR ALLOGENIC STEM CELL TRANSPLANTATION
US6558662B2 (en) * 1997-11-14 2003-05-06 The General Hospital Corporation Treatment of hematologic disorders
PE20100362A1 (es) * 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
WO2018136606A1 (en) * 2017-01-18 2018-07-26 Thalia Papayannopoulou Compositions and methods for transplant recipient conditioning

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
BR112021017728A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)